Amy Israel: Revolutionizing cancer medicine access in low- and middle-income countries
Amy Israel, Senior Advisor, Access to Medicines at Union for International Cancer Control, posted on LinkedIn about recent paper she and colleagues co-authored, titled “Revolutionising cancer treatment access in low-income and middle-income countries: a sustainable approach” published on The Lancet Oncology.
Authore: Amy Israela, Cary Adams, Gilberto Lopes, Dan Milner, Sumithra Krishnamurthy Reddiar
“It’s my honour to share our Lancet Oncology comment published this week highlighting the sustainable access pathways of the Access to Oncology Medicines (ATOM) – a critical step forward in revolutionizing cancer medicine access in low- and middle-income countries.
For those without full journal access, check out UICC’s blog on the piece here.
Thanks to our access pathway partners who enable this – Medicines Patent Pool, The Max Foundation and IDA Foundation and our partner companies who have publicly committed medicines Novartis, Bristol Myers Squibb, BeiGene and Servier. It takes a village!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023